EARNEST Partners
CRTX

EARNEST Partners’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

EARNEST Partners’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,500
Closed -$24K – 419
2013
Q4 		$24K Buy
+2,500
New +$23.7K ﹤0.01% 327

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

EARNEST Partners's CRTX Position: Q1 2014 in Review

EARNEST Partners sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 2,500 shares — an estimated $24K sold.

EARNEST Partners first reported a position in CRTX in Q4 2013 and held it in 1 quarter. The position peaked at $24K in Q4 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • EARNEST Partners reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • EARNEST Partners sold 2,500 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $24K.
  • EARNEST Partners first reported a position in CORNERSTONE THERAPEUTICS INC in Q4 2013 and held it in 1 quarter.
  • EARNEST Partners's CORNERSTONE THERAPEUTICS INC position peaked at $24K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on EARNEST Partners's 13F filing for Q1 2014, filed 15 May 2014.